NCT06962137
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06962137
Title Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer (RAINSPOT)
Acronym RAINSPOT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen KU Leuven
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Facility Status City State Zip Country Details
UZA NOT_YET_RECRUITING Antwerp Belgium Details
Cliniques Universitaires Saint-Luc Brussels NOT_YET_RECRUITING Brussels Belgium Details
HUB NOT_YET_RECRUITING Brussels Belgium Details
UZ Gent NOT_YET_RECRUITING Ghent Belgium Details
UZ Leuven RECRUITING Leuven 3000 Belgium Details
AZ Delta Roeselare NOT_YET_RECRUITING Roeselare Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field